Further on February 24 to 28 this year, 15 laboratory personnel were trained on HLA testing and gaining hands-on experience with the newly acquired equipment ...

As World Kidney Day approaches, Sri Lanka takes center stage in the global effort to address kidney health and organ transplantation. ..

To help lower the risk of organ rejection, it is crucial to find as close an HLA match between the donor and recipient as possible. While HLA typing has been around for decades, more recent ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 -- -- Advancing four clinical programs for hematologic malignancies and autoimmune diseases -- -- $249.4 ...

Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood disorders, today announced the successful completion of an approximately $50 ...

Anocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...

TuHURA Biosciences, Inc.’s HURA share price has surged by 15.15%, which has investors questioning if this is right time to sell.